Merit Medical Systems | MMSI - Operating Expenses


Merit Medical Systems reported $337.72M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
3M USD 3.26B 1.66B Mar/2026
Abbott USD 9.31B 104M Mar/2026
AngioDynamics USD 81.95M 1.68M Sep/2025
Anika Therapeutics USD 133.9M 103.93M Mar/2026
AtriCure USD 140.72M 2.71M Mar/2026
Baxter International USD 6.04B 2.85B Mar/2026
Becton, Dickinson and Co. USD 24.13B 19.54B Mar/2026
Boston Scientific USD 4.15B 107M Mar/2026
Cooper Companies USD 1.11B 301.2M Mar/2026
Dexcom USD 936.6M 0 Mar/2026
Edwards Lifesciences USD 1.13B 65.4M Mar/2026
Globus Medical USD 595.85M 49.26M Mar/2026
Haemonetics USD 134.99M 1.26M Dec/2025
ICU Medical USD 514.62M 4.48M Dec/2025
Insulet USD 639.7M 2.2M Mar/2026
Integra LifeSciences USD 1.04B 673.49M Mar/2026
J&J USD 17.44B 1.53B Mar/2026
Medtronic USD 7.72B 436M Mar/2026
Merit Medical Systems USD 337.72M 2.02M Mar/2026
Olympus JPY 268.42B 35.37B Mar/2026
Pfizer USD 90.1B 77.19B Mar/2026
STAAR Surgical USD 76.12M 7.38M Mar/2026
Stryker USD 4.92B 284M Mar/2026
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teleflex USD 3.08B 2.55B Mar/2026
Terumo JPY 268.87B 16.12B Mar/2026
Zimmer Biomet Holdings USD 1.69B 249.3M Mar/2026